BioPharma Dive 31. März 2026 Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026
BioPharma Dive 30. März 2026 United rises on IPF data; Biogen scores positive lupus data and an approval
BioPharma Dive 26. März 2026 Merck’s deal for Terns sparks debate over a possible biotech bidding war